Cargando…
Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR
Autophagy is a biological process that maintains cellular homeostasis and regulates the internal cellular environment. Hyperactivating autophagy to trigger cell death has been a suggested therapeutic strategy for cancer treatment. Mechanistic target of rapamycin (mTOR) is a crucial protein kinase th...
Autores principales: | Lee, Boah, Park, Seung Ju, Lee, Seulgi, Lee, Jinwook, Lee, Eunbeol, Yoo, Eun-Seon, Chung, Won-Suk, Sohn, Jong-Woo, Oh, Byung-Chul, Kim, Seyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279289/ https://www.ncbi.nlm.nih.gov/pubmed/35831271 http://dx.doi.org/10.1038/s41419-022-05039-6 |
Ejemplares similares
-
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
por: D’Erasmo, Laura, et al.
Publicado: (2022) -
Identification of the Antidepressant Vilazodone as an Inhibitor of Inositol Polyphosphate Multikinase by Structure-Based Drug Repositioning
por: Lee, Boah, et al.
Publicado: (2020) -
Ubiquilins Regulate Autophagic Flux through mTOR Signaling and Lysosomal Acidification
por: Şentürk, Mümine, et al.
Publicado: (2019) -
GIRK2 potassium channels expressed by the AgRP neurons decrease adiposity and body weight in mice
por: Oh, Youjin, et al.
Publicado: (2023) -
Glial Control of Synapse Number in Healthy and Diseased Brain
por: Lee, Eunbeol, et al.
Publicado: (2019)